Segui
Sébastien Héritier
Sébastien Héritier
Sorbonne Université
Email verificata su aphp.fr
Titolo
Citata da
Citata da
Anno
Diverse and targetable kinase alterations drive histiocytic neoplasms
EL Diamond, BH Durham, J Haroche, Z Yao, J Ma, SA Parikh, Z Wang, ...
Cancer discovery 6 (2), 154-165, 2016
4342016
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome
SHB Abina, HB Gaspar, J Blondeau, L Caccavelli, S Charrier, K Buckland, ...
Jama 313 (15), 1550-1563, 2015
4212015
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ...
Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017
2982017
BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy
S Héritier, JF Emile, MA Barkaoui, C Thomas, S Fraitag, S Boudjemaa, ...
Journal of clinical oncology 34 (25), 3023, 2016
2982016
Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study
J Donadieu, IA Larabi, M Tardieu, J Visser, C Hutter, E Sieni, N Kabbara, ...
Journal of Clinical Oncology 37 (31), 2857, 2019
1582019
Inherited CARD9 Deficiency in 2 Unrelated Patients With Invasive Exophiala Infection
F Lanternier, E Barbati, U Meinzer, L Liu, V Pedergnana, M Migaud, ...
The Journal of Infectious Diseases 211 (8), 1241-1250, 2015
1342015
Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency
F Hauck, C Randriamampita, E Martin, S Gerart, N Lambert, A Lim, ...
Journal of allergy and clinical immunology 130 (5), 1144-1152. e11, 2012
1182012
Vemurafenib use in an infant for high-risk Langerhans cell histiocytosis
S Héritier, M Jehanne, G Leverger, JF Emile, JC Alvarez, J Haroche, ...
JAMA oncology 1 (6), 836-838, 2015
1152015
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
C Rigaud, MA Barkaoui, C Thomas, Y Bertrand, A Lambilliotte, J Miron, ...
British journal of haematology 174 (6), 887-898, 2016
1072016
Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies
P Frange, F Touzot, M Debré, S Héritier, M Leruez-Ville, G Cros, ...
The Journal of infectious diseases 206 (8), 1269-1274, 2012
882012
Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey
TA Briggs, GI Rice, N Adib, L Ades, S Barete, K Baskar, V Baudouin, ...
Journal of clinical immunology 36, 220-234, 2016
782016
Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey
TA Briggs, GI Rice, N Adib, L Ades, S Barete, K Baskar, V Baudouin, ...
Journal of clinical immunology 36, 220-234, 2016
772016
Immune deficiency–related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency
R Lemoine, J Pachlopnik-Schmid, HF Farin, A Bigorgne, M Debré, ...
Journal of allergy and clinical immunology 134 (6), 1354-1364. e6, 2014
752014
Circulating cell‐free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis
S Héritier, Z Hélias‐Rodzewicz, H Lapillonne, N Terrones, S Garrigou, ...
British journal of haematology 178 (3), 457-467, 2017
742017
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
PG Kemps, J Picarsic, BH Durham, Z Hélias-Rodzewicz, L Hiemcke-Jiwa, ...
Blood, The Journal of the American Society of Hematology 139 (2), 256-280, 2022
682022
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study
S Héritier, MA Barkaoui, J Miron, C Thomas, D Moshous, A Lambilliotte, ...
British journal of haematology 183 (4), 608-617, 2018
622018
Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 2016; 6: 154–65 doi: 10.1158/2159-8290
EL Diamond, BH Durham, J Haroche, Z Yao, J Ma, SA Parikh, Z Wang, ...
CD-15-0913.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
47
New somatic BRAF splicing mutation in Langerhans cell histiocytosis
S Héritier, Z Hélias-Rodzewicz, R Chakraborty, AG Sengal, ...
Molecular Cancer 16, 1-5, 2017
412017
Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis
S Héritier, R Saffroy, N Radosevic-Robin, Y Pothin, H Pacquement, ...
Blood, The Journal of the American Society of Hematology 125 (15), 2448-2449, 2015
362015
Highly sensitive methods are required to detect mutations in histiocytoses
S Melloul, Z Hélias-Rodzewicz, F Cohen-Aubart, F Charlotte, S Fraitag, ...
Haematologica 104 (3), e97, 2019
302019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20